BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 1718703)

  • 1. An overview of therapeutic interventions in myocardial infarction. Emphasis on secondary prevention.
    Hinstridge V; Speight TM
    Drugs; 1991; 42 Suppl 2():8-20. PubMed ID: 1718703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic therapies after myocardial infarction.
    Rapaport E; Gheorghiade M
    Am J Med; 1996 Oct; 101(4A):4A61S-69S; discussion 4A69S-70S. PubMed ID: 8900339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prevention after myocardial infarction: in favor of beta-blockers.
    Lévy S
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S50-4. PubMed ID: 1707116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of beta blockade on sudden cardiac death during acute myocardial infarction and the postinfarction period.
    Hjalmarson A
    Am J Cardiol; 1997 Nov; 80(9B):35J-39J. PubMed ID: 9375948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advantages of beta blockers versus antiarrhythmic agents and calcium antagonists in secondary prevention after myocardial infarction.
    Singh BN
    Am J Cardiol; 1990 Sep; 66(9):9C-20C. PubMed ID: 1699400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of older persons after myocardial infarction.
    Aronow WS
    J Am Geriatr Soc; 1998 Nov; 46(11):1459-68. PubMed ID: 9809771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bivalirudin: a review of its potential place in the management of acute coronary syndromes.
    Carswell CI; Plosker GL
    Drugs; 2002; 62(5):841-70. PubMed ID: 11929334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Integration of therapeutic options and the candidates for treatment: the ABC of the post-infarction period].
    Ambrosioni E; Bacchelli S; Borghi C
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():132S-138S. PubMed ID: 9004813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy for acute myocardial infarction.
    Rich MW
    Clin Geriatr Med; 1996 Feb; 12(1):141-68. PubMed ID: 8653655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of arrhythmias during the first 24 hours of acute myocardial infarction treated with alteplase and effect of early administration of a beta-blocker or a bradycardiac agent on their incidence.
    Heidbüchel H; Tack J; Vanneste L; Ballet A; Ector H; Van de Werf F
    Circulation; 1994 Mar; 89(3):1051-9. PubMed ID: 8124790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment after myocardial infarction].
    Beurrier D; Danchin N
    Presse Med; 1994 Feb; 23(8):380-4. PubMed ID: 7911570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials.
    Yusuf S; Sleight P; Held P; McMahon S
    Circulation; 1990 Sep; 82(3 Suppl):II117-34. PubMed ID: 1975522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimising the use of beta-adrenoceptor antagonists in coronary artery disease.
    Ellison KE; Gandhi G
    Drugs; 2005; 65(6):787-97. PubMed ID: 15819591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines.
    Spinler SA; Hilleman DE; Cheng JW; Howard PA; Mauro VF; Lopez LM; Munger MA; Gardner SF; Nappi JM
    Ann Pharmacother; 2001 May; 35(5):589-617. PubMed ID: 11346067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.
    Roberts R; Rogers WJ; Mueller HS; Lambrew CT; Diver DJ; Smith HC; Willerson JT; Knatterud GL; Forman S; Passamani E
    Circulation; 1991 Feb; 83(2):422-37. PubMed ID: 1671346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The management of postthrombolysis patients].
    Branzi A; Melandri G; Galié N
    Cardiologia; 1991 Dec; 36(12 Suppl 1):413-9. PubMed ID: 1688159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical therapy of acute myocardial infarction: Part I. Role of thrombolytic and antithrombotic therapy.
    Jafri SM; Walters BL; Borzak S
    J Intensive Care Med; 1995; 10(2):54-63. PubMed ID: 10172420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.